Y3D-32046-62010 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-01-12
Registered in v-safe
2021-01-12
Dose 1 — Pfizer-BioNTech
2021-01-12
Health check-in — day 0, dose 1
Feeling: Good · None

Adult check-in
2021-01-13
Survey response — days 1–6 daily, dose 1
MedDRA: Dizziness — Feeling: Good · Diarrhea

Free text: 3 episodes Dizziness, less than 1 minute each episode.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-14
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-15
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Diarrhea

Adult check-in
2021-01-16
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-17
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-18
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-19
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2021-01-26
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-02-02
Dose 2 — Pfizer-BioNTech
2021-02-02
Survey response — day 0, dose 2
MedDRA: Disturbance in attention, Dizziness — Feeling: Good · Site: Pain · Fatigue or tiredness, Nausea, Rash, not including the immediate area around the injection site

Free text: Near dizziness...floating sensation with difficulty concentrating

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-03
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Fatigue or tiredness, Diarrhea

Adult check-in
2021-02-04
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Fatigue or tiredness, Diarrhea

Adult check-in
2021-02-05
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-02-06
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Fatigue or tiredness, Diarrhea

Adult check-in
2021-02-07
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-02-08
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Headache, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activities

Adult check-in
2021-02-09
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-02-16
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-02-23
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-03-02
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-03-09
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-03-17
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-05-06
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-08-03
Survey response — 6 months, dose 2
MedDRA: Cough, Nasal congestion, Oropharyngeal pain — Feeling: Fair · Be unable to work or attend school

Free text: Sore throat, nasal congestion , cough

MedDRA releases: 2021-09,2024-11 · check-in free text available
2022-02-05
Survey response — 12 months, dose 2
MedDRA: Arthralgia, Brain fog, COVID-19, Cough, Dyspnoea, Exercise tolerance decreased, Fatigue, Headache, Insomnia, Myalgia, Neuralgia, Peripheral vascular disorder, Pyrexia, Rash, Sinus congestion, Vertigo — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Covid + 12/28/21, joint and muscle pain, fever, SOB, cough, vertigo, headache, sinus congestion, extreme fatigue, activity intolerance, neuralgias, mental fog, insomnia, circulatory changes hands feet, rash face/ chest; still wax wane since RTW 1/11

MedDRA releases: 2024-11 · check-in free text available
2022-02-05
Report sent to call center — 12 months, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-02-11
Call successful
Not applicable (accidental reporting or does not believe symptoms are related to vaccine)

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-01-12	Pfizer-BioNTech
2	2021-02-02	Pfizer-BioNTech

Call center

Reported	Outcome	VAERS-related outcome
2022-02-05	Successful 2022-02-11	Not applicable (accidental reporting or does not believe symptoms are related to vaccine)

Free text

Release 1 — days 1–6 daily, dose 1

2021-01-13

Systemic reaction (other): 3 episodes Dizziness, less than 1 minute each episode.

Release 3 — day 0, dose 2

2021-02-02

Systemic reaction (other): Near dizziness...floating sensation with difficulty concentrating

Release 9 — 6 months, dose 2

2021-08-03

Symptoms: Sore throat, nasal congestion , cough

Release 11 — 12 months, dose 2

2022-02-05

Symptoms: Covid + 12/28/21, joint and muscle pain, fever, SOB, cough, vertigo, headache, sinus congestion, extreme fatigue, activity intolerance, neuralgias, mental fog, insomnia, circulatory changes hands feet, rash face/ chest; still wax wane since RTW 1/11 cut off by CDC

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Arthralgia	·	·	✓
SD	Brain fog	·	·	✓
SD	Cough	✓	·	✓
SD	COVID-19	·	·	✓
SD	Dyspnoea	·	·	✓
SD	Exercise tolerance decreased	·	·	✓
SD	Fatigue	·	·	✓
SD	Headache	·	·	✓
SD	Insomnia	·	·	✓
SD	Myalgia	·	·	✓
SD	Nasal congestion	✓	·	✓
SD	Neuralgia	·	·	✓
SD	Oropharyngeal pain	✓	·	✓
SD	Peripheral vascular disorder	·	·	✓
SD	Pyrexia	·	·	✓
SD	Rash	·	·	✓
SD	Sinus congestion	·	·	✓
SD	Vertigo	·	·	✓
SRO	Disturbance in attention	✓	✓	✓
SRO	Dizziness	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release